SlideShare a Scribd company logo
Lecture 1:
What Is Evidence-Based Physical Diagnosis?
Marc Imhotep Cray, M.D.
Evidence-Based
Physical Diagnosis
Marc Imhotep Cray, M.D.
Goals
2
The goals of this presentation are
 To elucidate the term evidence-based physical diagnosis.
 To provide the learner with a first-layer understanding
modern-day physical diagnosis.
 To demonstrate how concepts in basic epidemiology,
biostatistics and probability serve as requisites to
applying clinical epidemiology, evidence-based medicine
and thus, evidence-based physical diagnosis in core
clerkships.
Marc Imhotep Cray, M.D.
“Icebreaker Admonition”
3
“Read with two objectives: First to acquaint yourself with
the current knowledge on the subject and the steps by
which it has been reached; and secondly, and more
important, read to understand and analyze your cases.”
From: LeBlond RF, et al. DeGowin’s Diagnostic Examination, 10th Ed. New York:
McGraw-Hill Education, 2015; xxxi.
Originally: Sir William Osler
“The Student Life”
Marc Imhotep Cray, M.D.
Why is Diagnosis Important?
4
Medical history and physical examination (H&P) are
basis for diagnostic hypothesis generation the first
step in the diagnostic process
Accurate Dx precedes three tasks central to healing
professions: explanation, prognostication & therapy
 These three tasks provide answers to patient’s three
fundamental questions:
1. What is happening to me and why?
2. What does this mean or my future?
3. What can be done about it, how will that change my future?
Marc Imhotep Cray, M.D.
Why is Diagnosis Important cont’d.
5
 Failure to pursue a Dx  may permit a disease to
progress from curable to incurable
 Contrastly, for many complaints, in otherwise healthy
people w no alarm Sx or Sn a good prognosis can be
determined w/o knowing exact cause of complaint
 For example, an upper respiratory infection (URI)
o An experienced clinician can reassure pt. further testing is
unnecessary and will not change Px or Tx
Marc Imhotep Cray, M.D.
Why is Diagnosis Important cont’d.
6
 It takes…
 Experience,
 Knowledge of the medical literature,
 Good judgment, and
 Understanding of fundamentals of clinical
epidemiology and decision making
…to determine when pursuit of specific Sx & Sn is
warranted
Note: For a first-rate review of principles of epidemiology, see Fletcher et al.
[Fletcher RH, Fletcher SW, Fletcher GS. Clinical Epidemiology, the Essentials. 5th
ed. Baltimore, MD: Lippincott, Williams & Wilkens, 2012].
Marc Imhotep Cray, M.D.
Review of Diagnostic process:
(9 Sequential Steps)
7
Step 1: Take a History: Elicit symptoms and a timeline; begin a
problem list.
Step 2: Develop Hypotheses: Generate a mental list of anatomic sites
of disease, pathophysiologic processes, and diseases that might
produce the symptoms.
Step 3: Perform a Physical Examination: Look for signs of physiologic
processes and diseases suggested by history, and identify new
findings for problem list.
Step 4: Make a Problem List: List ALL problems found during history
and PE that require an explanation.
Marc Imhotep Cray, M.D.
Diagnostic process steps cont’d.
8
Step 5: Generate a Differential Diagnosis: List most probable
diagnostic hypotheses with an estimate of their pretest
probabilities.
Step 6: Test the Hypotheses: Select laboratory tests, imaging
studies, and other procedures with appropriate likelihood ratios to
evaluate your hypotheses.
Step 7: Modify Your Differential Diagnosis: Use test results to
evaluate your hypotheses, eliminating some, adding others, and
adjusting probabilities.
Step 8: Repeat Steps 1 to 7: Reiterate your process until you have
reached a diagnosis or decided that a definite diagnosis is neither
likely nor necessary.
Marc Imhotep Cray, M.D.
Diagnostic process steps cont’d.
9
Step 9: Make the Diagnosis or Diagnoses: When tests of your
hypotheses are of sufficient certainty that they meet your stopping
rule you have reached a diagnosis.
 If uncertain, consider a provisional diagnosis or watchful
waiting.
 Decide whether more investigation (return to Step l),
consultation, treatment, or watchful observation is best course
based upon severity of illness, prognosis, and comorbidities.
To learn more: LeBlond RF, et al. Part 1: The Diagnostic Framework. In: DeGowin’s
Diagnostic Examination, 9th Ed. New York: McGraw-Hill Education, 2009; 1-47.
Marc Imhotep Cray, M.D.
Diagnosis
10
When clinicians diagnose disease, their intent is to place patient’s
experience into a particular category (or diagnosis) a process
implying specific pathogenesis, prognosis, and treatment
 This procedure allows clinicians to explain what is happening to patients
and to identify best way to restore pt’s health
 A century ago, such categorization of disease rested almost
entirely on empiric observation—what clinicians saw, heard, and
felt at patient’s bedside
 almost all diagnoses were based on traditional physical examination
Marc Imhotep Cray, M.D.
Diagnosis cont’d.
11
For example, if patients presented a century ago w
complaints of fever and cough,  Dx of lobar
pneumonia rested on presence of characteristic PE
findings of pneumonia =
 fever, tachycardia, tachypnea, grunting respirations, cyanosis,
↓ excursion of affected side, dullness to percussion, ↑ tactile
fremitus, ↓ breath sounds (later bronchial breath sounds),
abnormalities of vocal resonance (bronchophony, pectoriloquy,
and egophony), and crackles
o If findings were absent pt. did not have pneumonia
• Chest radiography played no role in diagnosis b/c it was not widely
available until early 1900s
Marc Imhotep Cray, M.D.
Diagnosis cont’d.
12
 Modern medicine, of course, relies on technology much more
than medicine did a century ago (to our patients’ advantage)
and for many modern categories of disease, diagnostic standard
is a technologic test
 For example, if patients present today with fever and cough
Dx of pneumonia is based on presence of an infiltrate on chest
radiograph
 Similarly, Dx of systolic murmurs depends on echocardiography
and that of ascites on abdominal ultrasonography
o In these disorders, clinician’s principal interest is result of technologic
test and decisions about Tx depend much more on tech result
than on,
o whether pt. exhibits egophony, radiation of murmur into neck, or
shifting dullness
Marc Imhotep Cray, M.D.
Dx a Century Ago
13
McGee S, Steven R. Evidence-based Physical Diagnosis, 4th Ed. Philadelphia, PA: Elsevier, 2018; Fig..1.1, 2.
“EVOLUTION OF THE DIAGNOSTIC STANDARD”…
Marc Imhotep Cray, M.D.
Dx in Modern Times
14
McGee S, Steven R. Evidence-based Physical Diagnosis, 4th Ed. Philadelphia,
PA: Elsevier, 2018; Fig..1.1, 2.
 One century ago, most Dx were
defined by bedside observation,
whereas
 Today technologic standards have a
much greater diagnostic role
 Nonetheless, there are many
examples today of Dx based solely
on bedside findings (Ex. appear in
large gray shaded box)
 Evidence-based physical diagnosis, on
other hand, principally addresses
those Dx defined by technologic
standards b/c it identifies those
traditional findings that accurately
predict result of technologic test
…“EVOLUTION OF THE DIAGNOSTIC STANDARD”
Marc Imhotep Cray, M.D.
Evidence-based medicine
15
 EBM is a modern term for application of clinical
epidemiology to care of patients it includes:
 Formulating specific “answerable” clinical questions,
 Finding best available research evidence bearing on those
questions,
 Judging evidence for its validity, and
 Integrating critical appraisal w clinician’s expertise & patient’s
situation and values
See previous lecture: Introduction to Evidence Based Medicine (EBM) .Ppt
Marc Imhotep Cray, M.D.
Dx in Modern Times cont’d.
16
Reliance on technology creates tension for medical
students* b/c they spend hours mastering
traditional exam yet later learn (when first appearing
wards) traditional exam pales in importance compared
to technology
 A realization prompting a fundamental question:
o What is true diagnostic value of traditional physical
examination? Is it outdated and best discarded? Is it completely
accurate and underutilized? Is the truth somewhere between
these two extremes?
* This tension applies most in Western and other
highly technologically reliant and wealthy societies.
Marc Imhotep Cray, M.D.
Dx in Modern Times cont’d.
17
 “EVOLUTION OF THE DIAGNOSTIC STANDARD” discussed above indicates
Dx today is split into two parts
 For some categories of disease diagnostic standard still
remains empiric observation— what clinician sees, hears, and
feels—just as it was for all diagnoses a century ago
 For example, how does a clinician know pt. has cellulitis?
Ans: Only way is to go to patient’s bedside and observe fever
and localized bright erythema, warmth, swelling, and
tenderness on leg
o There is no other way to make this diagnosis (technologic or not)
Marc Imhotep Cray, M.D. 18
NB: The purpose of the follow snippet of concepts
in basic epidemiology, biostatistics and probability
are entirely select, and only intended to support
understanding of how these concepts are applied
in clinical epidemiology, evidence-based medicine
and thus, evidence-based physical diagnosis.
To learn more student is referred to Public Health Sciences lectures
and the Sociology, Epidemiology/Population Health (SPH) &
Interpretation of the Medical Literature (EBM) cloud folders.
“Understanding the Evidence”
Marc Imhotep Cray, M.D.
Biostatistics Definitions
19
Incidence: The number of new cases of a disease in a population
over a specific period of time (=longitudinal)
Prevalence: The total number of people in a population affected
by a condition at one point in time (=cross-sectional)
Duration relates incidence to prevalence
For example:
 Upper respiratory infections (URIs) have a high incidence every year
during winter months but a low prevalence b/c most URIs resolve
quickly
Contrastly,
 Diabetes mellitus (DM) has a relatively low incidence but high
prevalence b/c a patient who has diabetes has it for life
Marc Imhotep Cray, M.D.
Statistics for Diagnostic Tests
20
 True positive (Tp): Disease is present and diagnostic test is
positive  a correct result
 True negative (Tn): Disease is absent and diagnostic test is
negative  a correct result
 False positive (Fp): Disease is absent and diagnostic test is
positive  an incorrect result
 False negative (Fn): Disease is present and diagnostic test is
negative  an incorrect result
Marc Imhotep Cray, M.D.
Statistics for Diagnostic Tests:
Sensitivity
21
 Sensitivity: Given disease is present, probability that test will be
positive
 Stated another way, sensitivity is ability of a test to become
positive in presence of the disease
 It is defined as Tp/(Tp + Fn) or Tp/(total number of people
with disease)
 Sensitive tests are useful for screening b/c there are few false
negatives
 A highly sensitive test can, therefore, rule out the disease
o Consider the mnemonic SN-N-OUT= for a test that is SeNsitive, a
Negative result rules OUT a disease
Marc Imhotep Cray, M.D.
Statistics for Diagnostic Tests:
Sensitivity cont’d.
22
 Example: An HIV test with 98% sensitivity means that, when a
disease is present, it will be detected 98% of time
 Example: Consider a test that was positive 100% of time
regardless of presence or absence of disease
 It would technically have 100% sensitivity b/c it would be
positive in all patients with disease (but would be clinically
useless b/c it would be positive in all patients without
disease, too)
o Therefore, sensitivity is not whole picture when it comes to test
characteristics specificity is also important
Marc Imhotep Cray, M.D.
Statistics for Diagnostic Tests
23
 Specificity: Given disease is absent, probability that test will be
negative
 Stated another way specificity is ability of a test to remain
negative in absence of disease
 It is defined as Tn/(Tn + Fp) or Tn/(total number of people
without disease)
 Tests with high specificity are useful to confirm a diagnosis b/c
there are few false positives
 A highly specific test can, therefore, rule in the disease
o Consider the mnemonic SP-P-IN—for a test that is SPecific, a Positive
result rules IN a disease
For Example: An HIV test with 98% specificity means that, when a disease is
absent, test will be negative 98% of time
Marc Imhotep Cray, M.D.
Statistics for Diagnostic Tests:
PPV & NPV
24
Positive Predictive Value (PPV): Given test is positive, probability
that disease is present
 PPV = TP/(TP + FP) or TP/(total number of positive tests)
o For example, if a computed tomography (CT) scan has 98%
specificity for appendicitis, then given a positive finding of
appendicitis, patient will truly have disease 98% of time
 Negative Predictive Value (NPV): Given test is negative,
probability that the disease is absent
 NPV = TN/(TN + FN) or TN/(total number of negative tests)
o For example, if an HIV test has 98% NPV, then given a negative test,
patient will truly be HIV negative 98% of time
Marc Imhotep Cray, M.D.
Evaluation of diagnostic tests
25
 Uses 2 × 2 table comparing test results w actual presence of
disease TP, FP, TN, FN
 Sensitivity and specificity are fixed properties of a test
 PPV and NPV vary depending on disease prevalence in
population being tested
Marc Imhotep Cray, M.D.
Pre- and post-test probability
26
Pre-test probability and post-test probability (pretest and
posttest probability) are probabilities of presence of a condition
(such as a disease) before and after a diagnostic test, respectively
Post-test probability, in turn, can be positive or negative
depending on whether test falls out as a positive test or a
negative test, respectively
Ability to make a difference betw. pre- and post-test
probabilities of various conditions is a major factor in indication
of medical tests
Marc Imhotep Cray, M.D.
Pre- and post-test probability
cont’d.
27
Estimation of post-test probability: In clinical practice,
post-test probabilities are often just roughly estimated
 This is acceptable in finding of a pathognomonic Sn or Sx in
which case it is almost certain target condition is present;
or
 In absence of finding a sine qua non Sn or Sx in which case
it is almost certain target condition is absent
Marc Imhotep Cray, M.D.
Pre- and post-test probability
cont’d.
28
In reality, subjective probability of presence of a
condition is never exactly 0 or 100%
 Yet, there are several systematic methods to estimate that
probability (eg. likelihood ratios [next slide]) methods are
based on previously having performed test on a reference
group in which presence or absence of condition is known (a
test that is considered highly accurate= "Gold standard")
o These data are used to interpret test result of any individual tested
by method
Marc Imhotep Cray, M.D.
Likelihood ratios (LRs) in
diagnostic testing
29
 In EBM, likelihood ratios are used for assessing value of
performing a diagnostic test (=PE, Lab or other Dx study)
 Use sensitivity and specificity of test to determine whether a test
result usefully changes probability that a condition (such as a
disease state) exists
Application
 A likelihood ratio of greater than 1 indicates test result is associated
with disease
 A likelihood ratio less than 1  indicates test result is assoc. w absence
of disease
 Tests where likelihood ratios lie close to 1 have little practical
significance as post-test probability (odds) is little different from pre-
test probability
Marc Imhotep Cray, M.D.
Calculation of likelihood ratio
30
Two versions of likelihood ratio exist
 one for positive and one for negative test results
respectively, known as
o positive likelihood ratio (LR+, likelihood ratio positive, likelihood
ratio for positive results) and
o negative likelihood ratio (LR–, likelihood ratio negative, likelihood
ratio for negative results)
Positive likelihood ratio is calculated as
which is equivalent to
 Or " probability of a person who has disease testing positive divided by probability
of a person who does not have disease testing positive“
o "T+" or "T−" denote that result of test is positive or negative, respectively
o "D+" or "D−" denote that disease is present or absent, respectively
 "true positives" are those that test positive (T+) and have disease (D+), and
 "false positives" are those that test positive (T+) but do not have disease (D−)
Marc Imhotep Cray, M.D.
Calculation of likelihood ratio
cont’d.
31
Negative likelihood ratio is calculated as
which is equivalent to
 or "probability of a person who has disease testing negative divided by
probability of a person who does not have disease testing negative."
Pretest odds of a particular diagnosis X multiplied by
likelihood ratio= determines post-test odds (calculation is
based on Bayes' theorem )
 MKSAP Audio 1-07 – General Medicine_The Bayes Theorem (Offline)
Note : Odds can be calculated from, and then converted to, probability
Marc Imhotep Cray, M.D.
Likelihood ratios: Key Points
32
Likelihood ratios (LRs) are diagnostic weights= numbers
that quickly convey to clinicians how much a physical
sign argues for or against disease
 LRs have possible values between 0 and ∞
o Values greater than 1 ↑probability of disease (greater value of LR,
greater ↑in probability)
 LRs less than 1 decrease probability of disease (closer
number is to zero, more probability of disease ↓)
 LRs that equal 1 do not change probability of disease at all
Marc Imhotep Cray, M.D.
LRs Key Points cont’d.
33
 LRs of 2, 5, and 10 increase probability of disease about 15%,
30%, and 45%, respectively (in absolute terms)
 LRs of 0.5, 0.2, and 0.1 (i.e., reciprocals of 2, 5, and 10)
decrease probability 15%, 30%, and 45%, respectively
 Tables comparing LRs of different physical signs quickly inform
clinicians about which findings have greatest diagnostic value
See: Medical Likelihood Ratio Repository
The Likelihood Ratio Database
Marc Imhotep Cray, M.D.
Easy Estimation Table
34
 Use this table to estimate how likelihood ratio changes probability without
needing a calculator
Likelihood ratios in diagnostic testing. Article is issued from WikiMed Medical Encyclopedia - version 9/28/2016.
Marc Imhotep Cray, M.D.
Estimation Example
35
1.Pre-test probability: For example, if about 2 out of every 5
patients with abdominal distension have ascites, then pretest
probability is 40%
2.Likelihood Ratio: An example "test" is that the physical exam
finding of bulging flanks has a positive likelihood ratio of 2.0 for
ascites
3.Estimated change in probability: Based on table of previous slide,
a likelihood ratio of 2.0 corresponds to an approximately + 15%
increase in probability
4.Final (post-test) probability: Therefore, bulging flanks increases
probability of ascites from 40% to about 55% (i.e., 40% + 15% =
55%, which is within 2% off exact probability of 57%)
Marc Imhotep Cray, M.D.
Calculation Example
36
 An example is likelihood that a given test result would be expected in a
patient with a certain disorder compared to likelihood that same result
would occur in a patient without target disorder
 A worked example: A diagnostic test w sensitivity 67% and specificity 91% is applied
to 2, 030 people to look for a disorder with a population prevalence of 1.48%
Likelihood ratios in diagnostic testing. Article is issued from WikiMed Medical Encyclopedia - version 9/28/2016.
37
THE END
See next slide for further study tools.
Marc Imhotep Cray, M.D.
Further study:
38
Recommended textbook reading
 McGee S, Steven R. Evidence-based Physical Diagnosis, 4th Ed.
Philadelphia, PA: Elsevier, 2018; 1-18.
Cloud folders
 Sociology, Epidemiology/Population Health (SPH)
 Interpretation of the Medical Literature (EBM)

More Related Content

What's hot

Journal club - Cohort
Journal club - CohortJournal club - Cohort
Journal club - Cohort
Subraham Pany
 
RA-ILD
RA-ILDRA-ILD
RA-ILD
Marwa Besar
 
Surveillance Head and Neck Cancer
Surveillance Head and Neck CancerSurveillance Head and Neck Cancer
Surveillance Head and Neck Cancer
Michiel van den Brekel
 
Oral steroids in acute wheezing and asthma journal club
Oral steroids in acute wheezing and asthma journal clubOral steroids in acute wheezing and asthma journal club
Oral steroids in acute wheezing and asthma journal club
Surg Lt Cdr Manas Ranjan Mishra
 
Experts decision making schemes 2018 tababa ytb 2 ss1
Experts decision making schemes 2018 tababa ytb 2   ss1Experts decision making schemes 2018 tababa ytb 2   ss1
Experts decision making schemes 2018 tababa ytb 2 ss1
Imad Hassan
 
Sincope guidelines
Sincope guidelinesSincope guidelines
Sincope guidelinesgisa_legal
 
Derivation and validation of an exclusive pre operative risk evaluation syste...
Derivation and validation of an exclusive pre operative risk evaluation syste...Derivation and validation of an exclusive pre operative risk evaluation syste...
Derivation and validation of an exclusive pre operative risk evaluation syste...
Clinical Surgery Research Communications
 
Journal club review; Pediatrics
Journal club review; PediatricsJournal club review; Pediatrics
Journal club review; Pediatrics
Cpu Ctekla
 
Lung Poorly differentiated Adenocarcinoma with Cerebral Metastases
Lung Poorly differentiated Adenocarcinoma with Cerebral MetastasesLung Poorly differentiated Adenocarcinoma with Cerebral Metastases
Lung Poorly differentiated Adenocarcinoma with Cerebral Metastases
asclepiuspdfs
 
Convalescent Plasma and COVID-19: Ancient Therapy Re-emerged
Convalescent Plasma and COVID-19: Ancient Therapy Re-emergedConvalescent Plasma and COVID-19: Ancient Therapy Re-emerged
Convalescent Plasma and COVID-19: Ancient Therapy Re-emerged
asclepiuspdfs
 
Journal club presentation
Journal club presentationJournal club presentation
Journal club presentation
Lutful Haque
 
Journal club pediatrics medicine
Journal club pediatrics medicineJournal club pediatrics medicine
Journal club pediatrics medicine
Nehal Shah
 
Eldabe_et_al-2015-Neuromodulation-_Technology_at_the_Neural_Interface
Eldabe_et_al-2015-Neuromodulation-_Technology_at_the_Neural_InterfaceEldabe_et_al-2015-Neuromodulation-_Technology_at_the_Neural_Interface
Eldabe_et_al-2015-Neuromodulation-_Technology_at_the_Neural_InterfaceSimon Thomson
 
Lutheran Research Fair-- Tachycardia and Troponin
Lutheran Research Fair-- Tachycardia and TroponinLutheran Research Fair-- Tachycardia and Troponin
Lutheran Research Fair-- Tachycardia and TroponinSunil E. Saith, MD, MPH
 
Consenso de Fibrose Pulmonar Idiopática da ATS
Consenso de Fibrose Pulmonar Idiopática da ATSConsenso de Fibrose Pulmonar Idiopática da ATS
Consenso de Fibrose Pulmonar Idiopática da ATSFlávia Salame
 
Final ipf journal club presentation
Final ipf journal club presentationFinal ipf journal club presentation
Final ipf journal club presentation
katejohnpunag
 
Journal club - Disease progression in hemodynamically stable patients present...
Journal club - Disease progression in hemodynamically stable patients present...Journal club - Disease progression in hemodynamically stable patients present...
Journal club - Disease progression in hemodynamically stable patients present...
Farooq Khan
 
Journal Club presentation on Outbreak Investigation Study
Journal Club presentation on Outbreak Investigation Study   Journal Club presentation on Outbreak Investigation Study
Journal Club presentation on Outbreak Investigation Study
Kunal Modak
 
Drs. Lorenzen and Barlock’s CMC X-Ray Mastery Project: October Cases
Drs. Lorenzen and Barlock’s CMC X-Ray Mastery Project: October CasesDrs. Lorenzen and Barlock’s CMC X-Ray Mastery Project: October Cases
Drs. Lorenzen and Barlock’s CMC X-Ray Mastery Project: October Cases
Sean M. Fox
 

What's hot (20)

Journal club - Cohort
Journal club - CohortJournal club - Cohort
Journal club - Cohort
 
Bacterial meningitis
Bacterial meningitisBacterial meningitis
Bacterial meningitis
 
RA-ILD
RA-ILDRA-ILD
RA-ILD
 
Surveillance Head and Neck Cancer
Surveillance Head and Neck CancerSurveillance Head and Neck Cancer
Surveillance Head and Neck Cancer
 
Oral steroids in acute wheezing and asthma journal club
Oral steroids in acute wheezing and asthma journal clubOral steroids in acute wheezing and asthma journal club
Oral steroids in acute wheezing and asthma journal club
 
Experts decision making schemes 2018 tababa ytb 2 ss1
Experts decision making schemes 2018 tababa ytb 2   ss1Experts decision making schemes 2018 tababa ytb 2   ss1
Experts decision making schemes 2018 tababa ytb 2 ss1
 
Sincope guidelines
Sincope guidelinesSincope guidelines
Sincope guidelines
 
Derivation and validation of an exclusive pre operative risk evaluation syste...
Derivation and validation of an exclusive pre operative risk evaluation syste...Derivation and validation of an exclusive pre operative risk evaluation syste...
Derivation and validation of an exclusive pre operative risk evaluation syste...
 
Journal club review; Pediatrics
Journal club review; PediatricsJournal club review; Pediatrics
Journal club review; Pediatrics
 
Lung Poorly differentiated Adenocarcinoma with Cerebral Metastases
Lung Poorly differentiated Adenocarcinoma with Cerebral MetastasesLung Poorly differentiated Adenocarcinoma with Cerebral Metastases
Lung Poorly differentiated Adenocarcinoma with Cerebral Metastases
 
Convalescent Plasma and COVID-19: Ancient Therapy Re-emerged
Convalescent Plasma and COVID-19: Ancient Therapy Re-emergedConvalescent Plasma and COVID-19: Ancient Therapy Re-emerged
Convalescent Plasma and COVID-19: Ancient Therapy Re-emerged
 
Journal club presentation
Journal club presentationJournal club presentation
Journal club presentation
 
Journal club pediatrics medicine
Journal club pediatrics medicineJournal club pediatrics medicine
Journal club pediatrics medicine
 
Eldabe_et_al-2015-Neuromodulation-_Technology_at_the_Neural_Interface
Eldabe_et_al-2015-Neuromodulation-_Technology_at_the_Neural_InterfaceEldabe_et_al-2015-Neuromodulation-_Technology_at_the_Neural_Interface
Eldabe_et_al-2015-Neuromodulation-_Technology_at_the_Neural_Interface
 
Lutheran Research Fair-- Tachycardia and Troponin
Lutheran Research Fair-- Tachycardia and TroponinLutheran Research Fair-- Tachycardia and Troponin
Lutheran Research Fair-- Tachycardia and Troponin
 
Consenso de Fibrose Pulmonar Idiopática da ATS
Consenso de Fibrose Pulmonar Idiopática da ATSConsenso de Fibrose Pulmonar Idiopática da ATS
Consenso de Fibrose Pulmonar Idiopática da ATS
 
Final ipf journal club presentation
Final ipf journal club presentationFinal ipf journal club presentation
Final ipf journal club presentation
 
Journal club - Disease progression in hemodynamically stable patients present...
Journal club - Disease progression in hemodynamically stable patients present...Journal club - Disease progression in hemodynamically stable patients present...
Journal club - Disease progression in hemodynamically stable patients present...
 
Journal Club presentation on Outbreak Investigation Study
Journal Club presentation on Outbreak Investigation Study   Journal Club presentation on Outbreak Investigation Study
Journal Club presentation on Outbreak Investigation Study
 
Drs. Lorenzen and Barlock’s CMC X-Ray Mastery Project: October Cases
Drs. Lorenzen and Barlock’s CMC X-Ray Mastery Project: October CasesDrs. Lorenzen and Barlock’s CMC X-Ray Mastery Project: October Cases
Drs. Lorenzen and Barlock’s CMC X-Ray Mastery Project: October Cases
 

Similar to Evidence-Based Physical Diagnosis_Lect. 1_ What is Evidence-Based Physical Diagnosis

The patient perspective_v3_final
The patient perspective_v3_finalThe patient perspective_v3_final
The patient perspective_v3_final
Donald Freeman
 
The patient perspective nat caplyme final
The patient perspective nat caplyme finalThe patient perspective nat caplyme final
The patient perspective nat caplyme final
natcaplyme
 
History Taking and Physical Examination- An Overview
History Taking and Physical Examination- An OverviewHistory Taking and Physical Examination- An Overview
History Taking and Physical Examination- An Overview
Imhotep Virtual Medical School
 
Epidemiology of periodontal diseases By Dr. Abhishek Gaur (8741095005)
Epidemiology of periodontal diseases By Dr. Abhishek Gaur (8741095005)Epidemiology of periodontal diseases By Dr. Abhishek Gaur (8741095005)
Epidemiology of periodontal diseases By Dr. Abhishek Gaur (8741095005)
Dr. Abhishek Ashok Sharma
 
An Introduction To Research Methods
An Introduction To Research MethodsAn Introduction To Research Methods
An Introduction To Research Methods
Valerie Felton
 
Common medical diagnosis -an algorithmic approach --3rd ed
Common medical diagnosis -an algorithmic approach --3rd edCommon medical diagnosis -an algorithmic approach --3rd ed
Common medical diagnosis -an algorithmic approach --3rd ed
DR YONG & ASSOCIATES Family Health
 
1. Epidemiology_Lecture_07.09.2023.pptx,
1. Epidemiology_Lecture_07.09.2023.pptx,1. Epidemiology_Lecture_07.09.2023.pptx,
1. Epidemiology_Lecture_07.09.2023.pptx,
GowthamSelvaraj21
 
An introduction to experimental epidemiology
An introduction to experimental epidemiology An introduction to experimental epidemiology
An introduction to experimental epidemiology
improvemed
 
Evidence based Orthopedics
Evidence based OrthopedicsEvidence based Orthopedics
Evidence based Orthopedics
Abdulla Kamal
 
Research Methodolgy introduction
Research Methodolgy  introductionResearch Methodolgy  introduction
Research Methodolgy introduction
Hinda Hassan
 
Crossectional studies 2
Crossectional studies 2Crossectional studies 2
Crossectional studies 2Bruno Mmassy
 
Experimental epidemiology
 Experimental epidemiology Experimental epidemiology
Experimental epidemiology
improvemed
 
EXPERIMENTAL EPIDEMIOLOGY
EXPERIMENTAL EPIDEMIOLOGYEXPERIMENTAL EPIDEMIOLOGY
EXPERIMENTAL EPIDEMIOLOGY
improvemed
 
719 747
719 747719 747
719 747
yasserflaifal
 
Epidemiology for enviromental Health.pptx
Epidemiology for enviromental Health.pptxEpidemiology for enviromental Health.pptx
Epidemiology for enviromental Health.pptx
yeabT
 
Casecontrolstudy
CasecontrolstudyCasecontrolstudy
Casecontrolstudy
Sarah Sheela Nemalladinne
 
Medical Laboratory Sciences
Medical Laboratory SciencesMedical Laboratory Sciences
Medical Laboratory Sciences
Tapeshwar Yadav
 
final pathophysiology.pptx
final pathophysiology.pptxfinal pathophysiology.pptx
final pathophysiology.pptx
VandanaChandan1
 
Principles of diseses outbreak.in our societypptx
Principles of diseses outbreak.in our societypptxPrinciples of diseses outbreak.in our societypptx
Principles of diseses outbreak.in our societypptx
w2tz2qrqxd
 

Similar to Evidence-Based Physical Diagnosis_Lect. 1_ What is Evidence-Based Physical Diagnosis (20)

The patient perspective_v3_final
The patient perspective_v3_finalThe patient perspective_v3_final
The patient perspective_v3_final
 
The patient perspective nat caplyme final
The patient perspective nat caplyme finalThe patient perspective nat caplyme final
The patient perspective nat caplyme final
 
History Taking and Physical Examination- An Overview
History Taking and Physical Examination- An OverviewHistory Taking and Physical Examination- An Overview
History Taking and Physical Examination- An Overview
 
Epidemiology of periodontal diseases By Dr. Abhishek Gaur (8741095005)
Epidemiology of periodontal diseases By Dr. Abhishek Gaur (8741095005)Epidemiology of periodontal diseases By Dr. Abhishek Gaur (8741095005)
Epidemiology of periodontal diseases By Dr. Abhishek Gaur (8741095005)
 
An Introduction To Research Methods
An Introduction To Research MethodsAn Introduction To Research Methods
An Introduction To Research Methods
 
Common medical diagnosis -an algorithmic approach --3rd ed
Common medical diagnosis -an algorithmic approach --3rd edCommon medical diagnosis -an algorithmic approach --3rd ed
Common medical diagnosis -an algorithmic approach --3rd ed
 
1. Epidemiology_Lecture_07.09.2023.pptx,
1. Epidemiology_Lecture_07.09.2023.pptx,1. Epidemiology_Lecture_07.09.2023.pptx,
1. Epidemiology_Lecture_07.09.2023.pptx,
 
An introduction to experimental epidemiology
An introduction to experimental epidemiology An introduction to experimental epidemiology
An introduction to experimental epidemiology
 
Evidence based Orthopedics
Evidence based OrthopedicsEvidence based Orthopedics
Evidence based Orthopedics
 
Research Methodolgy introduction
Research Methodolgy  introductionResearch Methodolgy  introduction
Research Methodolgy introduction
 
Crossectional studies 2
Crossectional studies 2Crossectional studies 2
Crossectional studies 2
 
Experimental epidemiology
 Experimental epidemiology Experimental epidemiology
Experimental epidemiology
 
EXPERIMENTAL EPIDEMIOLOGY
EXPERIMENTAL EPIDEMIOLOGYEXPERIMENTAL EPIDEMIOLOGY
EXPERIMENTAL EPIDEMIOLOGY
 
719 747
719 747719 747
719 747
 
NANOROBOT IN BIOMEDICIENE
NANOROBOT IN BIOMEDICIENENANOROBOT IN BIOMEDICIENE
NANOROBOT IN BIOMEDICIENE
 
Epidemiology for enviromental Health.pptx
Epidemiology for enviromental Health.pptxEpidemiology for enviromental Health.pptx
Epidemiology for enviromental Health.pptx
 
Casecontrolstudy
CasecontrolstudyCasecontrolstudy
Casecontrolstudy
 
Medical Laboratory Sciences
Medical Laboratory SciencesMedical Laboratory Sciences
Medical Laboratory Sciences
 
final pathophysiology.pptx
final pathophysiology.pptxfinal pathophysiology.pptx
final pathophysiology.pptx
 
Principles of diseses outbreak.in our societypptx
Principles of diseses outbreak.in our societypptxPrinciples of diseses outbreak.in our societypptx
Principles of diseses outbreak.in our societypptx
 

More from Imhotep Virtual Medical School

Oncologic Pathology_A Case-based Organ Systems Review (USMLE Step 1)
Oncologic Pathology_A Case-based Organ Systems Review (USMLE Step 1)Oncologic Pathology_A Case-based Organ Systems Review (USMLE Step 1)
Oncologic Pathology_A Case-based Organ Systems Review (USMLE Step 1)
Imhotep Virtual Medical School
 
Pathology and Pathophysiology of Shock
Pathology and Pathophysiology of ShockPathology and Pathophysiology of Shock
Pathology and Pathophysiology of Shock
Imhotep Virtual Medical School
 
Drugs Used In Disorders of the Reproductive System
Drugs Used In Disorders of the Reproductive SystemDrugs Used In Disorders of the Reproductive System
Drugs Used In Disorders of the Reproductive System
Imhotep Virtual Medical School
 
Reproductive System Pathology_FM Breast and FM Reproductive Systems
Reproductive System Pathology_FM Breast and FM Reproductive SystemsReproductive System Pathology_FM Breast and FM Reproductive Systems
Reproductive System Pathology_FM Breast and FM Reproductive Systems
Imhotep Virtual Medical School
 
Reproductive System Pathology_Male Reproductive Systems
Reproductive System Pathology_Male Reproductive SystemsReproductive System Pathology_Male Reproductive Systems
Reproductive System Pathology_Male Reproductive Systems
Imhotep Virtual Medical School
 
Nervous System Pathology_A Case-based Learning Approach
Nervous System Pathology_A Case-based Learning ApproachNervous System Pathology_A Case-based Learning Approach
Nervous System Pathology_A Case-based Learning Approach
Imhotep Virtual Medical School
 
CVS Function, Regulation of the Heart and Overview of Therapeutic Goals in CV...
CVS Function, Regulation of the Heart and Overview of Therapeutic Goals in CV...CVS Function, Regulation of the Heart and Overview of Therapeutic Goals in CV...
CVS Function, Regulation of the Heart and Overview of Therapeutic Goals in CV...
Imhotep Virtual Medical School
 
Cardiovascular Pathology Case-based_Gross and Microscopic
Cardiovascular Pathology Case-based_Gross and MicroscopicCardiovascular Pathology Case-based_Gross and Microscopic
Cardiovascular Pathology Case-based_Gross and Microscopic
Imhotep Virtual Medical School
 
HIV / AIDS Pathology
HIV / AIDS PathologyHIV / AIDS Pathology
HIV / AIDS Pathology
Imhotep Virtual Medical School
 
Sepsis & Septic Shock
Sepsis & Septic ShockSepsis & Septic Shock
Sepsis & Septic Shock
Imhotep Virtual Medical School
 
Drugs Used in infectious Disease_Antibiotics
Drugs Used in infectious Disease_AntibioticsDrugs Used in infectious Disease_Antibiotics
Drugs Used in infectious Disease_Antibiotics
Imhotep Virtual Medical School
 
Hematopoietic and Lymphoid Systems Pathology
Hematopoietic and Lymphoid Systems  PathologyHematopoietic and Lymphoid Systems  Pathology
Hematopoietic and Lymphoid Systems Pathology
Imhotep Virtual Medical School
 
Drugs Used in Neoplastic Disorders
Drugs Used in Neoplastic DisordersDrugs Used in Neoplastic Disorders
Drugs Used in Neoplastic Disorders
Imhotep Virtual Medical School
 
Neoplasia & Oncologic Pathology
Neoplasia & Oncologic PathologyNeoplasia & Oncologic Pathology
Neoplasia & Oncologic Pathology
Imhotep Virtual Medical School
 
Clinical Pharmacology for Medical Students_USMLE Step 1 & 2 Review
Clinical Pharmacology for Medical Students_USMLE Step 1 & 2 ReviewClinical Pharmacology for Medical Students_USMLE Step 1 & 2 Review
Clinical Pharmacology for Medical Students_USMLE Step 1 & 2 Review
Imhotep Virtual Medical School
 
Make the Dx_ A Case-based Intro to Select Cardiovascular and Respiratory Dise...
Make the Dx_ A Case-based Intro to Select Cardiovascular and Respiratory Dise...Make the Dx_ A Case-based Intro to Select Cardiovascular and Respiratory Dise...
Make the Dx_ A Case-based Intro to Select Cardiovascular and Respiratory Dise...
Imhotep Virtual Medical School
 
Myocardial infarction_ Causes, Symptoms, Diagnosis, Treatment, and Pathology
Myocardial infarction_ Causes, Symptoms, Diagnosis, Treatment, and PathologyMyocardial infarction_ Causes, Symptoms, Diagnosis, Treatment, and Pathology
Myocardial infarction_ Causes, Symptoms, Diagnosis, Treatment, and Pathology
Imhotep Virtual Medical School
 
Basic CXR Interpretation_Diagnostic Radiographs
Basic CXR Interpretation_Diagnostic RadiographsBasic CXR Interpretation_Diagnostic Radiographs
Basic CXR Interpretation_Diagnostic Radiographs
Imhotep Virtual Medical School
 
Electrocardiogram (ECG) Interpretation_Module 1 of 2
Electrocardiogram (ECG) Interpretation_Module 1 of 2Electrocardiogram (ECG) Interpretation_Module 1 of 2
Electrocardiogram (ECG) Interpretation_Module 1 of 2
Imhotep Virtual Medical School
 
Autonomic Nervous System Physiology and Pharmacology_Overview| Review of ANS
Autonomic Nervous System Physiology and Pharmacology_Overview| Review of ANSAutonomic Nervous System Physiology and Pharmacology_Overview| Review of ANS
Autonomic Nervous System Physiology and Pharmacology_Overview| Review of ANS
Imhotep Virtual Medical School
 

More from Imhotep Virtual Medical School (20)

Oncologic Pathology_A Case-based Organ Systems Review (USMLE Step 1)
Oncologic Pathology_A Case-based Organ Systems Review (USMLE Step 1)Oncologic Pathology_A Case-based Organ Systems Review (USMLE Step 1)
Oncologic Pathology_A Case-based Organ Systems Review (USMLE Step 1)
 
Pathology and Pathophysiology of Shock
Pathology and Pathophysiology of ShockPathology and Pathophysiology of Shock
Pathology and Pathophysiology of Shock
 
Drugs Used In Disorders of the Reproductive System
Drugs Used In Disorders of the Reproductive SystemDrugs Used In Disorders of the Reproductive System
Drugs Used In Disorders of the Reproductive System
 
Reproductive System Pathology_FM Breast and FM Reproductive Systems
Reproductive System Pathology_FM Breast and FM Reproductive SystemsReproductive System Pathology_FM Breast and FM Reproductive Systems
Reproductive System Pathology_FM Breast and FM Reproductive Systems
 
Reproductive System Pathology_Male Reproductive Systems
Reproductive System Pathology_Male Reproductive SystemsReproductive System Pathology_Male Reproductive Systems
Reproductive System Pathology_Male Reproductive Systems
 
Nervous System Pathology_A Case-based Learning Approach
Nervous System Pathology_A Case-based Learning ApproachNervous System Pathology_A Case-based Learning Approach
Nervous System Pathology_A Case-based Learning Approach
 
CVS Function, Regulation of the Heart and Overview of Therapeutic Goals in CV...
CVS Function, Regulation of the Heart and Overview of Therapeutic Goals in CV...CVS Function, Regulation of the Heart and Overview of Therapeutic Goals in CV...
CVS Function, Regulation of the Heart and Overview of Therapeutic Goals in CV...
 
Cardiovascular Pathology Case-based_Gross and Microscopic
Cardiovascular Pathology Case-based_Gross and MicroscopicCardiovascular Pathology Case-based_Gross and Microscopic
Cardiovascular Pathology Case-based_Gross and Microscopic
 
HIV / AIDS Pathology
HIV / AIDS PathologyHIV / AIDS Pathology
HIV / AIDS Pathology
 
Sepsis & Septic Shock
Sepsis & Septic ShockSepsis & Septic Shock
Sepsis & Septic Shock
 
Drugs Used in infectious Disease_Antibiotics
Drugs Used in infectious Disease_AntibioticsDrugs Used in infectious Disease_Antibiotics
Drugs Used in infectious Disease_Antibiotics
 
Hematopoietic and Lymphoid Systems Pathology
Hematopoietic and Lymphoid Systems  PathologyHematopoietic and Lymphoid Systems  Pathology
Hematopoietic and Lymphoid Systems Pathology
 
Drugs Used in Neoplastic Disorders
Drugs Used in Neoplastic DisordersDrugs Used in Neoplastic Disorders
Drugs Used in Neoplastic Disorders
 
Neoplasia & Oncologic Pathology
Neoplasia & Oncologic PathologyNeoplasia & Oncologic Pathology
Neoplasia & Oncologic Pathology
 
Clinical Pharmacology for Medical Students_USMLE Step 1 & 2 Review
Clinical Pharmacology for Medical Students_USMLE Step 1 & 2 ReviewClinical Pharmacology for Medical Students_USMLE Step 1 & 2 Review
Clinical Pharmacology for Medical Students_USMLE Step 1 & 2 Review
 
Make the Dx_ A Case-based Intro to Select Cardiovascular and Respiratory Dise...
Make the Dx_ A Case-based Intro to Select Cardiovascular and Respiratory Dise...Make the Dx_ A Case-based Intro to Select Cardiovascular and Respiratory Dise...
Make the Dx_ A Case-based Intro to Select Cardiovascular and Respiratory Dise...
 
Myocardial infarction_ Causes, Symptoms, Diagnosis, Treatment, and Pathology
Myocardial infarction_ Causes, Symptoms, Diagnosis, Treatment, and PathologyMyocardial infarction_ Causes, Symptoms, Diagnosis, Treatment, and Pathology
Myocardial infarction_ Causes, Symptoms, Diagnosis, Treatment, and Pathology
 
Basic CXR Interpretation_Diagnostic Radiographs
Basic CXR Interpretation_Diagnostic RadiographsBasic CXR Interpretation_Diagnostic Radiographs
Basic CXR Interpretation_Diagnostic Radiographs
 
Electrocardiogram (ECG) Interpretation_Module 1 of 2
Electrocardiogram (ECG) Interpretation_Module 1 of 2Electrocardiogram (ECG) Interpretation_Module 1 of 2
Electrocardiogram (ECG) Interpretation_Module 1 of 2
 
Autonomic Nervous System Physiology and Pharmacology_Overview| Review of ANS
Autonomic Nervous System Physiology and Pharmacology_Overview| Review of ANSAutonomic Nervous System Physiology and Pharmacology_Overview| Review of ANS
Autonomic Nervous System Physiology and Pharmacology_Overview| Review of ANS
 

Recently uploaded

How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 

Recently uploaded (20)

How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 

Evidence-Based Physical Diagnosis_Lect. 1_ What is Evidence-Based Physical Diagnosis

  • 1. Lecture 1: What Is Evidence-Based Physical Diagnosis? Marc Imhotep Cray, M.D. Evidence-Based Physical Diagnosis
  • 2. Marc Imhotep Cray, M.D. Goals 2 The goals of this presentation are  To elucidate the term evidence-based physical diagnosis.  To provide the learner with a first-layer understanding modern-day physical diagnosis.  To demonstrate how concepts in basic epidemiology, biostatistics and probability serve as requisites to applying clinical epidemiology, evidence-based medicine and thus, evidence-based physical diagnosis in core clerkships.
  • 3. Marc Imhotep Cray, M.D. “Icebreaker Admonition” 3 “Read with two objectives: First to acquaint yourself with the current knowledge on the subject and the steps by which it has been reached; and secondly, and more important, read to understand and analyze your cases.” From: LeBlond RF, et al. DeGowin’s Diagnostic Examination, 10th Ed. New York: McGraw-Hill Education, 2015; xxxi. Originally: Sir William Osler “The Student Life”
  • 4. Marc Imhotep Cray, M.D. Why is Diagnosis Important? 4 Medical history and physical examination (H&P) are basis for diagnostic hypothesis generation the first step in the diagnostic process Accurate Dx precedes three tasks central to healing professions: explanation, prognostication & therapy  These three tasks provide answers to patient’s three fundamental questions: 1. What is happening to me and why? 2. What does this mean or my future? 3. What can be done about it, how will that change my future?
  • 5. Marc Imhotep Cray, M.D. Why is Diagnosis Important cont’d. 5  Failure to pursue a Dx  may permit a disease to progress from curable to incurable  Contrastly, for many complaints, in otherwise healthy people w no alarm Sx or Sn a good prognosis can be determined w/o knowing exact cause of complaint  For example, an upper respiratory infection (URI) o An experienced clinician can reassure pt. further testing is unnecessary and will not change Px or Tx
  • 6. Marc Imhotep Cray, M.D. Why is Diagnosis Important cont’d. 6  It takes…  Experience,  Knowledge of the medical literature,  Good judgment, and  Understanding of fundamentals of clinical epidemiology and decision making …to determine when pursuit of specific Sx & Sn is warranted Note: For a first-rate review of principles of epidemiology, see Fletcher et al. [Fletcher RH, Fletcher SW, Fletcher GS. Clinical Epidemiology, the Essentials. 5th ed. Baltimore, MD: Lippincott, Williams & Wilkens, 2012].
  • 7. Marc Imhotep Cray, M.D. Review of Diagnostic process: (9 Sequential Steps) 7 Step 1: Take a History: Elicit symptoms and a timeline; begin a problem list. Step 2: Develop Hypotheses: Generate a mental list of anatomic sites of disease, pathophysiologic processes, and diseases that might produce the symptoms. Step 3: Perform a Physical Examination: Look for signs of physiologic processes and diseases suggested by history, and identify new findings for problem list. Step 4: Make a Problem List: List ALL problems found during history and PE that require an explanation.
  • 8. Marc Imhotep Cray, M.D. Diagnostic process steps cont’d. 8 Step 5: Generate a Differential Diagnosis: List most probable diagnostic hypotheses with an estimate of their pretest probabilities. Step 6: Test the Hypotheses: Select laboratory tests, imaging studies, and other procedures with appropriate likelihood ratios to evaluate your hypotheses. Step 7: Modify Your Differential Diagnosis: Use test results to evaluate your hypotheses, eliminating some, adding others, and adjusting probabilities. Step 8: Repeat Steps 1 to 7: Reiterate your process until you have reached a diagnosis or decided that a definite diagnosis is neither likely nor necessary.
  • 9. Marc Imhotep Cray, M.D. Diagnostic process steps cont’d. 9 Step 9: Make the Diagnosis or Diagnoses: When tests of your hypotheses are of sufficient certainty that they meet your stopping rule you have reached a diagnosis.  If uncertain, consider a provisional diagnosis or watchful waiting.  Decide whether more investigation (return to Step l), consultation, treatment, or watchful observation is best course based upon severity of illness, prognosis, and comorbidities. To learn more: LeBlond RF, et al. Part 1: The Diagnostic Framework. In: DeGowin’s Diagnostic Examination, 9th Ed. New York: McGraw-Hill Education, 2009; 1-47.
  • 10. Marc Imhotep Cray, M.D. Diagnosis 10 When clinicians diagnose disease, their intent is to place patient’s experience into a particular category (or diagnosis) a process implying specific pathogenesis, prognosis, and treatment  This procedure allows clinicians to explain what is happening to patients and to identify best way to restore pt’s health  A century ago, such categorization of disease rested almost entirely on empiric observation—what clinicians saw, heard, and felt at patient’s bedside  almost all diagnoses were based on traditional physical examination
  • 11. Marc Imhotep Cray, M.D. Diagnosis cont’d. 11 For example, if patients presented a century ago w complaints of fever and cough,  Dx of lobar pneumonia rested on presence of characteristic PE findings of pneumonia =  fever, tachycardia, tachypnea, grunting respirations, cyanosis, ↓ excursion of affected side, dullness to percussion, ↑ tactile fremitus, ↓ breath sounds (later bronchial breath sounds), abnormalities of vocal resonance (bronchophony, pectoriloquy, and egophony), and crackles o If findings were absent pt. did not have pneumonia • Chest radiography played no role in diagnosis b/c it was not widely available until early 1900s
  • 12. Marc Imhotep Cray, M.D. Diagnosis cont’d. 12  Modern medicine, of course, relies on technology much more than medicine did a century ago (to our patients’ advantage) and for many modern categories of disease, diagnostic standard is a technologic test  For example, if patients present today with fever and cough Dx of pneumonia is based on presence of an infiltrate on chest radiograph  Similarly, Dx of systolic murmurs depends on echocardiography and that of ascites on abdominal ultrasonography o In these disorders, clinician’s principal interest is result of technologic test and decisions about Tx depend much more on tech result than on, o whether pt. exhibits egophony, radiation of murmur into neck, or shifting dullness
  • 13. Marc Imhotep Cray, M.D. Dx a Century Ago 13 McGee S, Steven R. Evidence-based Physical Diagnosis, 4th Ed. Philadelphia, PA: Elsevier, 2018; Fig..1.1, 2. “EVOLUTION OF THE DIAGNOSTIC STANDARD”…
  • 14. Marc Imhotep Cray, M.D. Dx in Modern Times 14 McGee S, Steven R. Evidence-based Physical Diagnosis, 4th Ed. Philadelphia, PA: Elsevier, 2018; Fig..1.1, 2.  One century ago, most Dx were defined by bedside observation, whereas  Today technologic standards have a much greater diagnostic role  Nonetheless, there are many examples today of Dx based solely on bedside findings (Ex. appear in large gray shaded box)  Evidence-based physical diagnosis, on other hand, principally addresses those Dx defined by technologic standards b/c it identifies those traditional findings that accurately predict result of technologic test …“EVOLUTION OF THE DIAGNOSTIC STANDARD”
  • 15. Marc Imhotep Cray, M.D. Evidence-based medicine 15  EBM is a modern term for application of clinical epidemiology to care of patients it includes:  Formulating specific “answerable” clinical questions,  Finding best available research evidence bearing on those questions,  Judging evidence for its validity, and  Integrating critical appraisal w clinician’s expertise & patient’s situation and values See previous lecture: Introduction to Evidence Based Medicine (EBM) .Ppt
  • 16. Marc Imhotep Cray, M.D. Dx in Modern Times cont’d. 16 Reliance on technology creates tension for medical students* b/c they spend hours mastering traditional exam yet later learn (when first appearing wards) traditional exam pales in importance compared to technology  A realization prompting a fundamental question: o What is true diagnostic value of traditional physical examination? Is it outdated and best discarded? Is it completely accurate and underutilized? Is the truth somewhere between these two extremes? * This tension applies most in Western and other highly technologically reliant and wealthy societies.
  • 17. Marc Imhotep Cray, M.D. Dx in Modern Times cont’d. 17  “EVOLUTION OF THE DIAGNOSTIC STANDARD” discussed above indicates Dx today is split into two parts  For some categories of disease diagnostic standard still remains empiric observation— what clinician sees, hears, and feels—just as it was for all diagnoses a century ago  For example, how does a clinician know pt. has cellulitis? Ans: Only way is to go to patient’s bedside and observe fever and localized bright erythema, warmth, swelling, and tenderness on leg o There is no other way to make this diagnosis (technologic or not)
  • 18. Marc Imhotep Cray, M.D. 18 NB: The purpose of the follow snippet of concepts in basic epidemiology, biostatistics and probability are entirely select, and only intended to support understanding of how these concepts are applied in clinical epidemiology, evidence-based medicine and thus, evidence-based physical diagnosis. To learn more student is referred to Public Health Sciences lectures and the Sociology, Epidemiology/Population Health (SPH) & Interpretation of the Medical Literature (EBM) cloud folders. “Understanding the Evidence”
  • 19. Marc Imhotep Cray, M.D. Biostatistics Definitions 19 Incidence: The number of new cases of a disease in a population over a specific period of time (=longitudinal) Prevalence: The total number of people in a population affected by a condition at one point in time (=cross-sectional) Duration relates incidence to prevalence For example:  Upper respiratory infections (URIs) have a high incidence every year during winter months but a low prevalence b/c most URIs resolve quickly Contrastly,  Diabetes mellitus (DM) has a relatively low incidence but high prevalence b/c a patient who has diabetes has it for life
  • 20. Marc Imhotep Cray, M.D. Statistics for Diagnostic Tests 20  True positive (Tp): Disease is present and diagnostic test is positive  a correct result  True negative (Tn): Disease is absent and diagnostic test is negative  a correct result  False positive (Fp): Disease is absent and diagnostic test is positive  an incorrect result  False negative (Fn): Disease is present and diagnostic test is negative  an incorrect result
  • 21. Marc Imhotep Cray, M.D. Statistics for Diagnostic Tests: Sensitivity 21  Sensitivity: Given disease is present, probability that test will be positive  Stated another way, sensitivity is ability of a test to become positive in presence of the disease  It is defined as Tp/(Tp + Fn) or Tp/(total number of people with disease)  Sensitive tests are useful for screening b/c there are few false negatives  A highly sensitive test can, therefore, rule out the disease o Consider the mnemonic SN-N-OUT= for a test that is SeNsitive, a Negative result rules OUT a disease
  • 22. Marc Imhotep Cray, M.D. Statistics for Diagnostic Tests: Sensitivity cont’d. 22  Example: An HIV test with 98% sensitivity means that, when a disease is present, it will be detected 98% of time  Example: Consider a test that was positive 100% of time regardless of presence or absence of disease  It would technically have 100% sensitivity b/c it would be positive in all patients with disease (but would be clinically useless b/c it would be positive in all patients without disease, too) o Therefore, sensitivity is not whole picture when it comes to test characteristics specificity is also important
  • 23. Marc Imhotep Cray, M.D. Statistics for Diagnostic Tests 23  Specificity: Given disease is absent, probability that test will be negative  Stated another way specificity is ability of a test to remain negative in absence of disease  It is defined as Tn/(Tn + Fp) or Tn/(total number of people without disease)  Tests with high specificity are useful to confirm a diagnosis b/c there are few false positives  A highly specific test can, therefore, rule in the disease o Consider the mnemonic SP-P-IN—for a test that is SPecific, a Positive result rules IN a disease For Example: An HIV test with 98% specificity means that, when a disease is absent, test will be negative 98% of time
  • 24. Marc Imhotep Cray, M.D. Statistics for Diagnostic Tests: PPV & NPV 24 Positive Predictive Value (PPV): Given test is positive, probability that disease is present  PPV = TP/(TP + FP) or TP/(total number of positive tests) o For example, if a computed tomography (CT) scan has 98% specificity for appendicitis, then given a positive finding of appendicitis, patient will truly have disease 98% of time  Negative Predictive Value (NPV): Given test is negative, probability that the disease is absent  NPV = TN/(TN + FN) or TN/(total number of negative tests) o For example, if an HIV test has 98% NPV, then given a negative test, patient will truly be HIV negative 98% of time
  • 25. Marc Imhotep Cray, M.D. Evaluation of diagnostic tests 25  Uses 2 × 2 table comparing test results w actual presence of disease TP, FP, TN, FN  Sensitivity and specificity are fixed properties of a test  PPV and NPV vary depending on disease prevalence in population being tested
  • 26. Marc Imhotep Cray, M.D. Pre- and post-test probability 26 Pre-test probability and post-test probability (pretest and posttest probability) are probabilities of presence of a condition (such as a disease) before and after a diagnostic test, respectively Post-test probability, in turn, can be positive or negative depending on whether test falls out as a positive test or a negative test, respectively Ability to make a difference betw. pre- and post-test probabilities of various conditions is a major factor in indication of medical tests
  • 27. Marc Imhotep Cray, M.D. Pre- and post-test probability cont’d. 27 Estimation of post-test probability: In clinical practice, post-test probabilities are often just roughly estimated  This is acceptable in finding of a pathognomonic Sn or Sx in which case it is almost certain target condition is present; or  In absence of finding a sine qua non Sn or Sx in which case it is almost certain target condition is absent
  • 28. Marc Imhotep Cray, M.D. Pre- and post-test probability cont’d. 28 In reality, subjective probability of presence of a condition is never exactly 0 or 100%  Yet, there are several systematic methods to estimate that probability (eg. likelihood ratios [next slide]) methods are based on previously having performed test on a reference group in which presence or absence of condition is known (a test that is considered highly accurate= "Gold standard") o These data are used to interpret test result of any individual tested by method
  • 29. Marc Imhotep Cray, M.D. Likelihood ratios (LRs) in diagnostic testing 29  In EBM, likelihood ratios are used for assessing value of performing a diagnostic test (=PE, Lab or other Dx study)  Use sensitivity and specificity of test to determine whether a test result usefully changes probability that a condition (such as a disease state) exists Application  A likelihood ratio of greater than 1 indicates test result is associated with disease  A likelihood ratio less than 1  indicates test result is assoc. w absence of disease  Tests where likelihood ratios lie close to 1 have little practical significance as post-test probability (odds) is little different from pre- test probability
  • 30. Marc Imhotep Cray, M.D. Calculation of likelihood ratio 30 Two versions of likelihood ratio exist  one for positive and one for negative test results respectively, known as o positive likelihood ratio (LR+, likelihood ratio positive, likelihood ratio for positive results) and o negative likelihood ratio (LR–, likelihood ratio negative, likelihood ratio for negative results) Positive likelihood ratio is calculated as which is equivalent to  Or " probability of a person who has disease testing positive divided by probability of a person who does not have disease testing positive“ o "T+" or "T−" denote that result of test is positive or negative, respectively o "D+" or "D−" denote that disease is present or absent, respectively  "true positives" are those that test positive (T+) and have disease (D+), and  "false positives" are those that test positive (T+) but do not have disease (D−)
  • 31. Marc Imhotep Cray, M.D. Calculation of likelihood ratio cont’d. 31 Negative likelihood ratio is calculated as which is equivalent to  or "probability of a person who has disease testing negative divided by probability of a person who does not have disease testing negative." Pretest odds of a particular diagnosis X multiplied by likelihood ratio= determines post-test odds (calculation is based on Bayes' theorem )  MKSAP Audio 1-07 – General Medicine_The Bayes Theorem (Offline) Note : Odds can be calculated from, and then converted to, probability
  • 32. Marc Imhotep Cray, M.D. Likelihood ratios: Key Points 32 Likelihood ratios (LRs) are diagnostic weights= numbers that quickly convey to clinicians how much a physical sign argues for or against disease  LRs have possible values between 0 and ∞ o Values greater than 1 ↑probability of disease (greater value of LR, greater ↑in probability)  LRs less than 1 decrease probability of disease (closer number is to zero, more probability of disease ↓)  LRs that equal 1 do not change probability of disease at all
  • 33. Marc Imhotep Cray, M.D. LRs Key Points cont’d. 33  LRs of 2, 5, and 10 increase probability of disease about 15%, 30%, and 45%, respectively (in absolute terms)  LRs of 0.5, 0.2, and 0.1 (i.e., reciprocals of 2, 5, and 10) decrease probability 15%, 30%, and 45%, respectively  Tables comparing LRs of different physical signs quickly inform clinicians about which findings have greatest diagnostic value See: Medical Likelihood Ratio Repository The Likelihood Ratio Database
  • 34. Marc Imhotep Cray, M.D. Easy Estimation Table 34  Use this table to estimate how likelihood ratio changes probability without needing a calculator Likelihood ratios in diagnostic testing. Article is issued from WikiMed Medical Encyclopedia - version 9/28/2016.
  • 35. Marc Imhotep Cray, M.D. Estimation Example 35 1.Pre-test probability: For example, if about 2 out of every 5 patients with abdominal distension have ascites, then pretest probability is 40% 2.Likelihood Ratio: An example "test" is that the physical exam finding of bulging flanks has a positive likelihood ratio of 2.0 for ascites 3.Estimated change in probability: Based on table of previous slide, a likelihood ratio of 2.0 corresponds to an approximately + 15% increase in probability 4.Final (post-test) probability: Therefore, bulging flanks increases probability of ascites from 40% to about 55% (i.e., 40% + 15% = 55%, which is within 2% off exact probability of 57%)
  • 36. Marc Imhotep Cray, M.D. Calculation Example 36  An example is likelihood that a given test result would be expected in a patient with a certain disorder compared to likelihood that same result would occur in a patient without target disorder  A worked example: A diagnostic test w sensitivity 67% and specificity 91% is applied to 2, 030 people to look for a disorder with a population prevalence of 1.48% Likelihood ratios in diagnostic testing. Article is issued from WikiMed Medical Encyclopedia - version 9/28/2016.
  • 37. 37 THE END See next slide for further study tools.
  • 38. Marc Imhotep Cray, M.D. Further study: 38 Recommended textbook reading  McGee S, Steven R. Evidence-based Physical Diagnosis, 4th Ed. Philadelphia, PA: Elsevier, 2018; 1-18. Cloud folders  Sociology, Epidemiology/Population Health (SPH)  Interpretation of the Medical Literature (EBM)